Cefaclor is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azorian Pharma, Llc. The primary component is Cefaclor.
| Product ID | 81948-6250_a6a7fcf7-b9dc-4dac-b127-418588586a8a |
| NDC | 81948-6250 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cefaclor |
| Generic Name | Cefaclor |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-11-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA065412 |
| Labeler Name | Azorian Pharma, LLC |
| Substance Name | CEFACLOR |
| Active Ingredient Strength | 250 mg/5mL |
| Pharm Classes | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-11-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-1087 | Cefaclor | Cefaclor |
| 0143-9985 | CEFACLOR | CEFACLOR |
| 0143-9986 | CEFACLOR | CEFACLOR |
| 16571-070 | Cefaclor | Cefaclor |
| 16571-071 | Cefaclor | Cefaclor |
| 16571-072 | Cefaclor | Cefaclor |
| 21695-782 | CEFACLOR | CEFACLOR |
| 23594-125 | Cefaclor | cefaclor |
| 23594-250 | Cefaclor | cefaclor |
| 23594-375 | Cefaclor | cefaclor |
| 43063-194 | CEFACLOR | CEFACLOR |
| 50090-0518 | CEFACLOR | CEFACLOR |
| 50090-1602 | Cefaclor | Cefaclor |
| 59115-071 | CEFACLOR | CEFACLOR |
| 59115-072 | CEFACLOR | CEFACLOR |
| 61442-171 | Cefaclor | Cefaclor |
| 61442-172 | Cefaclor | Cefaclor |
| 61442-173 | Cefaclor | Cefaclor |
| 61442-174 | Cefaclor | Cefaclor |
| 61442-175 | Cefaclor | Cefaclor |
| 61442-176 | Cefaclor | Cefaclor |
| 63629-1007 | Cefaclor | Cefaclor |
| 68289-003 | Cefaclor | cefaclor |
| 68289-004 | Cefaclor | cefaclor |
| 81948-6250 | Cefaclor | cefaclor |